Mir-17* suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymes

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Xu, Yong ^a   Fang, Fang ^b   Zhang, Jiayou ^b   Josson, Sajni ^c   Clair, William H St ^b   Clair, Daret K St ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DISULFIRAM; GLUTATHIONE PEROXIDASE 2; LUCIFERASE; MANGANESE SUPEROXIDE DISMUTASE; MICRORNA; MICRORNA 17; TETRACYCLINE; THIOREDOXIN REDUCTASE 2; UNCLASSIFIED DRUG; ANTIOXIDANT; CARBAMIC ACID DERIVATIVE; DITHIOL DERIVATIVE; DRUG DERIVATIVE; GLUTATHIONE PEROXIDASE; GPX2 PROTEIN, HUMAN; MIRN17 MICRORNA, HUMAN; SUPEROXIDE DISMUTASE; TOLUENE;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL DEATH; CONTROLLED STUDY; ENZYME INHIBITION; GENE ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; REPORTER GENE; CHEMISTRY; GENE EXPRESSION REGULATION; METABOLISM; MITOCHONDRION; MULTIGENE FAMILY; PROSTATE TUMOR; TUMOR CELL LINE;

ANTIOXIDANTS; CARBAMATES; CELL LINE, TUMOR; DISULFIRAM; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MICRORNAS; MITOCHONDRIA; MULTIGENE FAMILY; PROSTATIC NEOPLASMS; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE 2; TOLUENE; TRANSFECTION;

EID: 78650982065     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014356     Document Type: Article

References (32)

1. Bartel DP (2004) Micro RNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Zamore PD, Haley B (2005) Ribo-gnome: The big world of small RNAs. Science 309: 1519-1524.
3. Mendell JT (2008) miRiad Roles for the miR-17-92 Cluster in Development and Disease. Cell 133: 217-222.
4. Venturini L, Battmer K, Castoldi M, Schultheis B, Hochhaus A, et al. (2007) Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 109: 4399-4405.
5. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, et al. (2005) A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
6. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) C-Mycregulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
7. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, et al. (2009) MiR-19 is a key oncogenic component of mir-17-92. Genes Dev 23: 2839-2849.
8. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261.
9. Niki E (2010) Assessment of Antioxidant Capacity in vitro and in vivo. Free Radic Biol Med 49: 503-515.
10. Fridovich I (1978) The biology of oxygen radicals. Science 201: 875-880.
11. Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL (2009) Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 390: 191-214.
12. Conrad M, Jakupoglu C, Moreno SG, Lippl S, Banjac A, et al. (2004) Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol 24: 9414-9423.
13. Szatrowski TP, Nathan CF (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794-798.
14. Toyokuni S, Okamoto K, Yodoi J, Hiai H (1995) Persistent oxidative stress in cancer. FEBS Lett 358: 1-3.
15. Reynolds AR, Kyprianou N (2006) Growth factor signalling in prostatic growth: significance in tumor development and therapeutic targeting. Br J Pharmacol Suppl 2: 144-152.
16. Josson S, Xu Y, Fang F, Dhar SK, St Clair DK, et al. (2006) RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells. Oncogene 25: 1554-1559.
17. Xu Y, Josson S, Fang F, Oberley TD, St Clair DK, et al. (2009) RelB enhances prostate cancer growth: implications for the role of the NF-kB alternative pathway in tumorigenicity. Cancer Res 69: 3267-3271.
18. Zhang X, Ladd A, Dragoescu E, Budd WT, Ware JL, et al. (2009) MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection. Clin Exp Metastasis 26: 965-979.
19. Xu Y, Kiningham KK, Devalaraja MN, Yeh CC, Majima H, et al. (1999) An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta. DNA Cell Biol 18: 709-722.
20. Chen D, Cui QC, Yang H, Dou QP (2006) Disulfiram, a clinically used antialcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res 66: 10425-10433.
21. Kim VN, Han J, Siomi MC (2009) Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10: 126-139.
22. Okamura K, Liu N, Lai EC (2009) Distinct mechanisms for microRNA strand selection by Drosophila Argonautes. Mol Cell 36: 431-444.
23. Boggs RM, Moody JA, Long CR, Tsai KL, Murphy KE (2007) Identification, amplification and characterization of miR-17-92 from canine tissue. Gene 404: 25-30.
24. Czech B, Zhou R, Erlich Y, Brennecke J, Binari R, et al. (2009) Hierarchical rules for Argonaute loading in Drosophila. Mol Cell 36: 445-456.
25. Ebi H, Sato T, Sugito N, Hosono Y, Yatabe Y, et al. (2009) Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers. Oncogene 28: 3371-3379.
26. Yan HL, Xue G, Mei Q, Wang YZ, Ding FX, et al. (2009) Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J 28: 2719-2732.
27. Taguchi A, Yanagisawa K, Tanaka M, Cao K, Matsuyama Y, et al. (2008) Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Res 68: 5540-5545.
28. Weinberg F, Chandel NS (2009) Mitochondrial metabolism and cancer. Ann NY Acad Sci 1177: 66-73.
29. Liou GY, Storz P (2010) Reactive oxygen species in cancer. Free Radic Res 44: 479-496.
30. Xu Y, Fang F, St Clair DK, Josson S, Sompol P, et al. (2007) Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1alpha,25-dihydroxyvitamin D(3) in prostate cancer cells. Mol Cancer Ther 7: 2048-2056.
31. Spitz DR, Oberley LW (1989) An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 179: 8-18.
32. Wheeler CR, Salzman JA, Elsayed NM, Omaye ST, Korte DW, Jr. (1990) Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal Biochem 184: 193-199.